Carson Wealth (CWM LLC)
KRYS icon

Carson Wealth (CWM LLC)’s Krystal Biotech KRYS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$384K Sell
1,488
-20
-1% -$5.32K ﹤0.01% 2216
2025
Q4 		$372K Sell
1,508
-28
-2% -$5.89K ﹤0.01% 2109
2025
Q3 		$271K Sell
1,536
-47
-3% -$7.04K ﹤0.01% 2213
2025
Q2 		$218K Buy
1,583
+107
+7% +$15.7K ﹤0.01% 2105
2025
Q1 		$266K Sell
1,476
-6,577
-82% -$1.11M ﹤0.01% 1742
2024
Q4 		$1.26M Sell
8,053
-5,793
-42% -$1.03M 0.01% 958
2024
Q3 		$2.52M Sell
13,846
-1,772
-11% -$342K 0.01% 632
2024
Q2 		$2.87M Sell
15,618
-8,232
-35% -$1.38M 0.01% 546
2024
Q1 		$4.24M Sell
23,850
-6,719
-22% -$933K 0.02% 451
2023
Q4 		$3.79M Sell
30,569
-1,757
-5% -$195K 0.02% 446
2023
Q3 		$3.75M Sell
32,326
-1,395
-4% -$170K 0.02% 416
2023
Q2 		$3.96M Sell
33,721
-1,444
-4% -$147K 0.02% 386
2023
Q1 		$2.81M Sell
35,165
-1,965
-5% -$154K 0.02% 426
2022
Q4 		$2.94M Sell
37,130
-6,254
-14% -$464K 0.02% 389
2022
Q3 		$3.02M Sell
43,384
-1,760
-4% -$127K 0.02% 357
2022
Q2 		$2.96M Sell
45,144
-7,159
-14% -$445K 0.02% 358
2022
Q1 		$3.48M Sell
52,303
-7,632
-13% -$476K 0.02% 340
2021
Q4 		$4.19M Buy
+59,935
New +$3.49M 0.03% 316
2021
Q2 		$4.22M Hold
62,112
– – 0.03% 301
2021
Q1 		$4.22M Hold
62,112
– – 0.03% 301
2020
Q4 		$4.22M Hold
62,112
– – 0.03% 301
2020
Q3 		$4.22M Hold
62,112
– – 0.03% 301
2020
Q2 		$4.22M Hold
62,112
– – 0.03% 301
2020
Q1 		$4.22M Hold
62,112
– – 0.03% 301
2019
Q4 		$4.22M Hold
62,112
– – 0.03% 301
2019
Q3 		$4.22M Hold
62,112
– – 0.03% 301
2019
Q2 		$4.22M Hold
62,112
– – 0.03% 301
2019
Q1 		$4.22M Buy
+62,112
New +$1.46M 0.03% 301

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carson Wealth (CWM LLC)'s KRYS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Krystal Biotech (KRYS) stake by 1.3% in Q1 2026, selling an estimated $5.32K and leaving 1,488 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Carson Wealth (CWM LLC) first reported a position in KRYS in Q1 2019 and has held it in 28 quarters since. The position peaked at $4.24M in Q1 2024. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,488 shares of Krystal Biotech worth $384K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 20 Krystal Biotech shares in Q1 2026, an estimated $5.32K.
  • Krystal Biotech made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2216 holding.
  • Carson Wealth (CWM LLC) first reported a position in Krystal Biotech in Q1 2019 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Krystal Biotech position peaked at $4.24M in Q1 2024.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.